Research and Markets: Global Non-Small Cell Lung Cancer Epidemiology and Patient Flow Analysis 2015

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/khrddh/global_nonsmall) has announced the addition of the "Global Non-Small Cell Lung Cancer Epidemiology and Patient Flow Analysis - 2015" report to their offering.

This report provides insights into Non-Small Cell Lung Cancer epidemiology, Non-Small Cell Lung Cancer diagnosed patients, and Non-Small Cell Lung Cancer treatment rate for top seven pharmaceutical markets. The study measures key indicators such as prevalence of Non-Small Cell Lung Cancer derived from epidemiological analysis, percentage of patients diagnosed with Non-Small Cell Lung Cancer, and percentage of patients treated with Non-Small Cell Lung Cancer therapy.

The study helps executives estimate Non-Small Cell Lung Cancer market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The report provides estimates and forecasts of Non-Small Cell Lung Cancer prevalence, Non-Small Cell Lung Cancer diagnosis rate, and Non-Small Cell Lung Cancer treatment rate for the period 2014 - 2020. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan. The study design is based on collection and interpretation of data from registries, scientific journals and literatures, government databases and other secondary sources.

Key Topics Covered:

1. Non-Small Cell Lung Cancer: Disease Definition

2. Global Non-Small Cell Lung Cancer Patient Flow

3. Non-Small Cell Lung Cancer Patient Flow in the US

4. Non-Small Cell Lung Cancer Patient Flow in Europe

5. Non-Small Cell Lung Cancer Patient Flow in Germany

6. Non-Small Cell Lung Cancer Patient Flow in France

7. Non-Small Cell Lung Cancer Patient Flow in Spain

8. Non-Small Cell Lung Cancer Patient Flow in Italy

9. Non-Small Cell Lung Cancer Patient Flow in UK

10. Non-Small Cell Lung Cancer Patient Flow in Japan

11. Appendix

For more information visit http://www.researchandmarkets.com/research/khrddh/global_nonsmall

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Healthcare and Medical Devices

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Healthcare and Medical Devices